Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IBD Ventures is the venture philanthropy arm of the Crohn's & Colitis Foundation, dedicated to accelerating the development of products that improve the lives of patients with inflammatory bowel disease (IBD). The program provides strategic funding and resources to companies and academic investigators to advance promising new treatments, diagnostics, and medical devices. By bridging the gap between early-stage research and clinical development, IBD Ventures aims to de-risk innovative projects and attract additional investment into the IBD space. The fund operates on a recycled model where any returns from successful investments are reinvested into future IBD research and development. Since its launch in 2017, it has supported a diverse portfolio of projects ranging from microbiome-based therapies to advanced surgical tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Colitis Foundation IBD Ventures.